The European Commission and vaccine makers Pfizer and BioNTech have reached agreement on amending the bloc’s 2021 supply deal for the duo’s Comirnaty mRNA-based shot. The compromise that extends the last planned delivery date to 2026 follows months of discussion, with member states urging the Commission to renegotiate the controversial deal.
Industry associations representing EU plastics producers, processors and users have called on the European Commission to develop transparent parameters for chemically recycled products.
Ahead of a summit of EU leaders on Mar. 23-24, the European Commission has shaken out a cornucopia of proposals to stimulate green investment in the 27-member bloc.
Two years after European Commission president Ursula von der Leyen and Pfizer CEO Albert Bourla virtually wrapped up a major order for the Covid-19 vaccine Comirnaty that the US drugmaker markets with Germany’s BioNTech, the New York Times is suing the Commission in the European Court of Justice for its failure to make essential details of the negotiations public.
The European Commission has provisionally renewed the license of the herbicide active ingredient glyphosate until the end of 2023. Earlier this year, the EU governing body had asked all member states to approve a one-year extension.
The European Commission has fined five companies a total of €157 million for forming a styrene cartel that operated from May 2012 to June 2018. Affected are Sunpor, Synbra, Synthomer, Synthos and Trinseo. As the member that blew the whistle in 2017, Ineos escaped a fine.
US biopharma PTC Therapeutics has entered into a financing collaboration with private equity group Blackstone so that it can achieve its goal of delivering at least one therapy every two-to-three years.
The European Commission proposed last month an emergency intervention in Europe’s energy markets to address recent dramatic price rises as the EU faces the effects of a severe mismatch between energy demand and supply. What is in the proposal?
